Literature DB >> 3554993

Kidney function in pregnant women.

J M Davison.   

Abstract

In pregnancy, glomerular filtration rate (GFR) and effective renal plasma flow (ERPF) increase to levels approximately 50% to 80% above nonpregnant levels. The increments occur shortly after conception and persist throughout the second trimester, with some reduction in late pregnancy. There is no accelerated growth akin to compensatory hypertrophy. The increased excretion of glucose and other nutrients in as well uric acid and protein is related in part to altered tubular function. These changes in renal physiology are so marked that nonpregnant norms cannot be used for the management of pregnant women. Cognizance of all these alterations is essential if kidney problems in pregnancy are to be suspected, detected, and managed correctly.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3554993     DOI: 10.1016/s0272-6386(87)80117-8

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  16 in total

1.  Modified renal function in pregnancy: impact on emtricitabine pharmacokinetics.

Authors:  Elodie Valade; Jean-Marc Tréluyer; François Dabis; Elise Arrivé; Emmanuelle Pannier; Sihem Benaboud; Floris Fauchet; Naïm Bouazza; Frantz Foissac; Saïk Urien; Déborah Hirt
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

2.  Pregnancy-related effects on lamivudine pharmacokinetics in a population study with 228 women.

Authors:  Sihem Benaboud; Jean Marc Tréluyer; Saik Urien; Stéphane Blanche; Naim Bouazza; Hélène Chappuy; Elisabeth Rey; Emmanuelle Pannier; Ghislaine Firtion; Odile Launay; Déborah Hirt
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

3.  Pregnancy-related effects on tenofovir pharmacokinetics: a population study with 186 women.

Authors:  Sihem Benaboud; Déborah Hirt; Odile Launay; Emmanuelle Pannier; Ghislaine Firtion; Elisabeth Rey; Naïm Bouazza; Frantz Foissac; Hélène Chappuy; Saik Urien; Jean Marc Tréluyer
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

4.  Gestational urinary hyperthiosulfaturia protects hypercalciuric normal pregnant women from nephrolithiasis.

Authors:  Hippocrates Yatzidis
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

5.  Changes in the metabolic clearance of vasopressin and in plasma vasopressinase throughout human pregnancy.

Authors:  J M Davison; E A Sheills; W M Barron; A G Robinson; M D Lindheimer
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

6.  Abnormal increases in urinary albumin excretion during pregnancy in IDDM women with pre-existing microalbuminuria.

Authors:  G Biesenbach; J Zazgornik; H Stöger; P Grafinger; R Hubmann; W Kaiser; O Janko; U Stuby
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 7.  Matrix metalloproteinases as drug targets in preeclampsia.

Authors:  Ana C T Palei; Joey P Granger; Jose E Tanus-Santos
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

8.  Evidence for attenuation of myo-inositol uptake, phosphoinositide turnover and inositol phosphate production in aortic vasculature of rats during pregnancy.

Authors:  K P Conrad; S A Barrera; P A Friedman; V M Schmidt
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

Review 9.  Paradoxes of body fluid volume regulation in health and disease. A unifying hypothesis.

Authors:  R W Schrier; M Niederberger
Journal:  West J Med       Date:  1994-10

10.  Pregnancy in women with prosthetic heart valves.

Authors:  P G Pieper; A Balci; A P Van Dijk
Journal:  Neth Heart J       Date:  2008-12       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.